Azimutus Europe

/ 52 Clarendon House Cornmarket Street

OX1 3HJ Oxford

GB

Azimutus Europe

Foundation date

01/09/2004

Sector

#Professional Services and Consulting

Subsector

Azimutus is a leading independent advisory firm specializing in M&A transaction advisory and growth capital.

Azimutus Biotech & Healthcare is based in Oxford and has strong links with the Oxford-Cambridge-London golden triangle. Our senior specialist team has extensive Biotech, Healthcare and Big Pharma experience and close ties to the European and US venture capital ecosystem.

Upcoming events

Latest news

  • Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

    Thursday November 30th 2023

  • Agomab appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer

    Wednesday November 29th 2023

  • Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure

    Wednesday November 29th 2023